Y, W., Y, A., Y, H., K, K., R, I., & T, I. (2018). Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Watanabe, Asami Y, Hirano Y, Kuribayashi K, Itamura R, y Imaeda T. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.
Cita MLA (8a ed.)Y, Watanabe, et al. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.